Lichen myxedematosus with plasma cell dyscrasia

1968 ◽  
Vol 97 (5) ◽  
pp. 606-608 ◽  
Author(s):  
P. Feldman
1965 ◽  
Vol 92 (1) ◽  
pp. 108a-110
Author(s):  
C. T. Nelson

1985 ◽  
Vol 22 (4) ◽  
pp. 425-431 ◽  
Author(s):  
J. MANASTER ◽  
M. AVIRAM ◽  
I. SILVIAN ◽  
J. CHEZAR ◽  
G. SPIRA

The Lancet ◽  
1978 ◽  
Vol 312 (8086) ◽  
pp. 425-426 ◽  
Author(s):  
Joseph Corkery ◽  
MurrayM. Bern ◽  
JamesL. Tullis

2016 ◽  
Vol 25 (6) ◽  
pp. 995-1005 ◽  
Author(s):  
Olga Baraldi ◽  
Valeria Grandinetti ◽  
Gabriele Donati ◽  
Giorgia Comai ◽  
Giuseppe Battaglino ◽  
...  

Leukemia ◽  
2001 ◽  
Vol 15 (1) ◽  
pp. 157-165 ◽  
Author(s):  
T Uchida ◽  
T Kinoshita ◽  
T Ohno ◽  
H Ohashi ◽  
H Nagai ◽  
...  

Medicine ◽  
1980 ◽  
Vol 59 (4) ◽  
pp. 311-322 ◽  
Author(s):  
P. A. BARDWICK ◽  
N. J. ZVAIFLER ◽  
G. N. GILL ◽  
D. NEWMAN ◽  
G. D. GREENWAY ◽  
...  

2021 ◽  
Author(s):  
Alex R Dinh ◽  
Sandy W Wong ◽  
Thomas G Martin ◽  
Jeffrey L Wolf ◽  
Allison B Webber

Author(s):  
W. A. Scherbaum ◽  
M. Schott

Autoimmune endocrinopathies arise from immunological abnormalities, which cause endocrine dysfunction by mimicking hormone action, by blocking the binding of hormones to their receptors, or by autoimmune-mediated destruction of endocrine glands. They include autoimmune polyglandular syndromes type I and type II, syndromes with anti-insulin receptor antibodies, POEMS syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) and thymic tumours with associated endocrinopathy. Box 10.2.5.1 gives an overview of the autoimmune endocrinopathies discussed in this chapter.


Sign in / Sign up

Export Citation Format

Share Document